Cytokinetics Plans Phase I/II Trial Of Ispinesib In First-Line Breast Cancer
This article was originally published in The Pink Sheet Daily
Executive Summary
Plan for the early stage program is announced simultaneously with disappointing outcomes from three mid-stage trials in various oncology settings.